VAXART INC VXRT
COM NEW · Common Stock · CUSIP 92243A200 · ISIN US92243A2006
American biotechnology company based in San Francisco
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSouth San Francisco, CA
- Founded2004
- Websitevaxart.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 240.1m as of 2025-11-06, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.36. Options: 1 managers hold calls ($1.0k notional), 1 hold puts ($0).
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 143 |
| Q4 2022 | 134 |
| Q1 2023 | 110 |
| Q2 2023 | 112 |
| Q3 2023 | 97 |
| Q4 2023 | 88 |
| Q1 2024 | 105 |
| Q2 2024 | 101 |
| Q3 2024 | 101 |
| Q4 2024 | 94 |
| Q1 2025 | 93 |
| Q2 2025 | 99 |
| Q3 2025 | 17 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 29 | 36 |
| Q1 2024 | 55 | 30 |
| Q2 2024 | 43 | 46 |
| Q3 2024 | 31 | 43 |
| Q4 2024 | 31 | 42 |
| Q1 2025 | 26 | 35 |
| Q2 2025 | 37 | 28 |
| Q3 2025 | 8 | 84 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2024 | $132.6k | $116.1k | 0.88 |
| Q1 2025 | $37.5k | $33.5k | 0.89 |
| Q2 2025 | $34.6k | $3.1k | 0.09 |
| Q3 2025 | $1.0k | $0 | 0.00 |
Biggest buyers
| MARSHALL WACE, LLP | Added | +189.2k |
| XTX Topco Ltd | Added | +70.4k |
| Custos Family Office, LLC | Added | +40.0k |
| Baader Bank Aktiengesellschaft | New | +12.1k |
| SIMPLEX TRADING, LLC | Added | +5.7k |
| Rockefeller Capital Management L.P. | New | +1.2k |
| Heritage Wealth Advisors | Added | +500 |
| Farther Finance Advisors, LLC | New | +27 |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -10.4m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -2.3m |
| BlackRock, Inc. | Sold out | -1.8m |
| STATE STREET CORP | Sold out | -851.1k |
| UBS Group AG | Sold out | -825.8k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -597.4k |
| ROYAL BANK OF CANADA | Sold out | -447.7k |
| Squarepoint Ops LLC | Sold out | -446.9k |
| NORTHERN TRUST CORP | Sold out | -409.2k |
| RAYMOND JAMES FINANCIAL INC | Sold out | -236.2k |
Biggest calls
| SIMPLEX TRADING, LLC | Reduced | $1.0k3.0k shares |
Biggest puts
| SIMPLEX TRADING, LLC | Reduced | $0500 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q3 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 1 | $13.6k | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 1 | $49.0k | 0 | — | — |
| Q3 2025 | 2 | $66.0k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-08-15 | Finney Kevin Director | Bought | $36.0k100.0k shares |
| 2025-07-30 | Finney Kevin Director | Bought | $9.8k25.9k shares |
| 2025-07-29 | Watson W. Mark Director | Bought | $4.1k10.0k shares |
| 2025-07-28 | Finney Kevin Director | Bought | $8.0k20.0k shares |
| 2025-07-25 | Finney Kevin Director | Bought | $7.8k20.0k shares |
| 2025-07-17 | Finney Kevin Director | Bought | $302794 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2025
| Manager | Shares | Change |
|---|---|---|
| MARSHALL WACE, LLP 0.00% of their portfolio | 2.0m $703.1k | Added +189.2k |
| XTX Topco Ltd 0.00% of their portfolio | 94.3k $34.4k | Added +70.4k |
| HBK Sorce Advisory LLC 0.00% of their portfolio | 75.1k $26.2k | Unchanged |
| Beacon Capital Management, LLC 0.00% of their portfolio | 60.3k $22.0k | Unchanged |
| Custos Family Office, LLC 0.01% of their portfolio | 50.0k $18.2k | Added +40.0k |
| LVM CAPITAL MANAGEMENT LTD/MI 0.00% of their portfolio | 25.0k $9.0k | Unchanged |
| Heritage Wealth Advisors 0.00% of their portfolio | 22.0k $8.0k | Added +500 |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 18.6k $6.0k | Added +5.7k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 14.2k $5.3k | Reduced -1.2k |
| Baader Bank Aktiengesellschaft 0.00% of their portfolio | 12.1k $2.7k | New |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.00% of their portfolio | 10.4k $3.6k | Unchanged |
| ORG Partners LLC 0.00% of their portfolio | 2.0k $729 | Unchanged |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 1.2k $429 | New |
| UMB Bank, n.a. 0.00% of their portfolio | 100 $36 | Unchanged |
| Concord Wealth Partners 0.00% of their portfolio | 75 $27 | Unchanged |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 27 $10 | New |
| Archer Investment Corp 0.00% of their portfolio | 15 $5 | Unchanged |